SCHEMBL5113448

SCHEMBL5113448

CC(C)C(=O)Nc1cccc(COc2c(Cl)cc(C(=O)NCC(=O)O)cc2Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SENP5 Q96HI0 3/20 0.52
SENP2 Q9HC62 3/20 0.52
SENP1 Q9P0U3 3/20 0.52
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
RAB9A P51151 4/20 0.47
NPC1 O15118 2/20 0.47
PLAU P00749 2/20 0.46
MRGPRX4 Q96LA9 1/20 0.43
PDE5A O76074 1/20 0.43
MAPT P10636 4/20 0.42
GAA P10253 2/20 0.42
TP53 P04637 1/20 0.42
TSHR P16473 1/20 0.42
HSD17B10 Q99714 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
HPGD P15428 2/20 0.41
ALDH1A1 P00352 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ALOX12 P18054 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5722614 0.95 SENP5 (0.49) SENP5SENP2SENP1MEN1KMT2A
SCHEMBL4350209 0.90 SENP5 (0.52) SENP5SENP2SENP1MEN1KMT2A
SCHEMBL5119979 0.89 MEN1 (0.50) SENP5SENP2SENP1MEN1KMT2A
SCHEMBL4924596 0.89 RAB9A (0.45) SENP5SENP2SENP1MEN1KMT2A
SCHEMBL5104457 0.88 SENP5 (0.41) SENP5SENP2SENP1MEN1KMT2A
SCHEMBL5722619 0.87 SENP5 (0.46) SENP5SENP2SENP1MEN1KMT2A
SCHEMBL5112743 0.87 SENP1 (0.52) SENP5SENP2SENP1MEN1KMT2A
SCHEMBL5117805 0.87 SENP5 (0.40) SENP5SENP2SENP1MEN1KMT2A
SCHEMBL4932507 0.86 RAB9A (0.47) SENP5SENP2SENP1MEN1KMT2A
SCHEMBL5110128 0.86 SENP5 (0.40) SENP5SENP2SENP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor KARO BIO AB (SE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor TSHR, TRHR, THRA SENP5 2379/4885SENP2 4509/4885SENP1 4088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.